Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clonidine Versus Adenosine to Treat Neuropathic Pain
NCT00349921Phase 2Completed
- Sponsor
- Wake Forest University Health Sciences
- Start
- Aug 2004
- Primary completion
- Jan 2008
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 2, randomised trial of clonidine and adenosine in complex regional pain syndrome type I (CRPS) (4 arms), sponsored by Wake Forest University Health Sciences. Primary endpoint: Number Meeting Success Criterion at 2 hours. Started Aug 2004; status: completed.
02
Drugs
clonidineadenosine
03
Conditions
complex regional pain syndrome type I (CRPS)
Beyond the preview
Go deeper on NCT00349921.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00349921.